ASP2151 Phase 1 Study - Multiple Oral Dosing Study in Healthy Non-elderly Male and Elderly Male Japanese Subjects-
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Amenamevir (Primary)
- Indications Herpes simplex virus infections; Herpes zoster
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Astellas Pharma
- 13 Nov 2017 Results of pooled data from four phase1 trial (NCT02852876, NCT02796118, 15L-CL-001 and 15L-CL-006) assessing safety and pharmacokinetics of single and multiple doses of amenamevir, were published in the Advances in Therapy.
- 25 Jun 2016 New trial record